Nicholas Pajewski to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications Nicholas Pajewski has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
0.049
-
Cohen JB, Marcum ZA, Zhang C, Derington CG, Greene TH, Ghazi L, Herrick JS, King JB, Cheung AK, Bryan N, Supiano MA, Sonnen JA, Weintraub WS, Scharfstein D, Williamson J, Pajewski NM, Bress AP. Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT). JAMA Netw Open. 2022 Jul 01; 5(7):e2220680.
Score: 0.049